Accession Number: | 0001171843-20-006337 |
Date: | 2020-09-03 |
Issuer: | ANIKA THERAPEUTICS, INC. (ANIK) |
Original Submission Date: |
RICHARD STEPHEN
32 WIGGINS AVENUE
BEDFORD, MA 01730
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-09-03 | A | 9,310 | a | $0.00 | 9,310 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | these shares represent restricted stock units. each restricted stock unit represents the contingent right to receive one share of anika therapeutics, inc. common stock. the restricted stock units vest in three equal annual installments immediately prior to the anika therapeutics, inc., annual meetings of stockholders in 2021, 2022, and 2023. |